Search Results Search Sort by RelevanceMost Recent State of the Art and Science Mar 2005 HEADSS: The "Review of Systems" for Adolescents Rachel Katzenellenbogen, MD Virtual Mentor. 2005;7(3):231-233. doi: 10.1001/virtualmentor.2005.7.3.cprl1-0503. Case and Commentary Feb 2005 Optional Treatments and Quality of Life, Commentary 1 Mary Jane Massie, MD Virtual Mentor. 2005;7(2):141-147. doi: 10.1001/virtualmentor.2005.7.2.ccas2-0502. Case and Commentary Feb 2005 Optional Treatments and Quality of Life, Commentary 2 Johannes Gobertus Meran, MD, MA Virtual Mentor. 2005;7(2):141-147. doi: 10.1001/virtualmentor.2005.7.2.ccas2-0502. State of the Art and Science Dec 2016 Locating Risk in the Adolescent Brain: Ethical Challenges in the Use of Biomarkers for Adolescent Health and Social Policy Suparna Choudhury, PhD and Sheehan Moore Neurobiological markers raise complex questions about what it means to be “at risk.” AMA J Ethics. 2016;18(12):1199-1206. doi: 10.1001/journalofethics.2016.18.12.stas1-1612. Case and Commentary Aug 2005 Hoping for the Best, Preparing for the Worst: Physician to Patient in Clinical Trial Frederic W. Platt, MD Virtual Mentor. 2005;7(8):541-546. doi: 10.1001/virtualmentor.2005.7.8.ccas2-0508. Case and Commentary Oct 2006 Coping with a Child's Conduct Disorder Sharon Hirsch, MD and Rebecca Sheffield Virtual Mentor. 2006;8(10):654-658. doi: 10.1001/virtualmentor.2006.8.10.ccas3-0610. State of the Art and Science Jan 2017 Ethical Considerations in Mandatory Disclosure of Data Acquired While Caring for Human Trafficking Survivors Patrick L. Kerr, PhD and Rachel Dash, ACSW, MSW Public health surveillance for infectious disease provides a model for a mandatory reporting policy for human trafficking, which poses risks for survivors. AMA J Ethics. 2017;19(1):45-53. doi: 10.1001/journalofethics.2017.19.1.stas1-1701. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. State of the Art and Science Nov 2004 Chronic Myeloid Leukemia and the Application of Rational Drug Design Richard Maury Stone, MD Virtual Mentor. 2004;6(11):497-500. doi: 10.1001/virtualmentor.2004.6.11.cprl1-0411. Pagination Current page 1 Page 2 Page 3 Page 4 Next page Next › Last page Last »
State of the Art and Science Mar 2005 HEADSS: The "Review of Systems" for Adolescents Rachel Katzenellenbogen, MD Virtual Mentor. 2005;7(3):231-233. doi: 10.1001/virtualmentor.2005.7.3.cprl1-0503.
Case and Commentary Feb 2005 Optional Treatments and Quality of Life, Commentary 1 Mary Jane Massie, MD Virtual Mentor. 2005;7(2):141-147. doi: 10.1001/virtualmentor.2005.7.2.ccas2-0502.
Case and Commentary Feb 2005 Optional Treatments and Quality of Life, Commentary 2 Johannes Gobertus Meran, MD, MA Virtual Mentor. 2005;7(2):141-147. doi: 10.1001/virtualmentor.2005.7.2.ccas2-0502.
State of the Art and Science Dec 2016 Locating Risk in the Adolescent Brain: Ethical Challenges in the Use of Biomarkers for Adolescent Health and Social Policy Suparna Choudhury, PhD and Sheehan Moore Neurobiological markers raise complex questions about what it means to be “at risk.” AMA J Ethics. 2016;18(12):1199-1206. doi: 10.1001/journalofethics.2016.18.12.stas1-1612.
Case and Commentary Aug 2005 Hoping for the Best, Preparing for the Worst: Physician to Patient in Clinical Trial Frederic W. Platt, MD Virtual Mentor. 2005;7(8):541-546. doi: 10.1001/virtualmentor.2005.7.8.ccas2-0508.
Case and Commentary Oct 2006 Coping with a Child's Conduct Disorder Sharon Hirsch, MD and Rebecca Sheffield Virtual Mentor. 2006;8(10):654-658. doi: 10.1001/virtualmentor.2006.8.10.ccas3-0610.
State of the Art and Science Jan 2017 Ethical Considerations in Mandatory Disclosure of Data Acquired While Caring for Human Trafficking Survivors Patrick L. Kerr, PhD and Rachel Dash, ACSW, MSW Public health surveillance for infectious disease provides a model for a mandatory reporting policy for human trafficking, which poses risks for survivors. AMA J Ethics. 2017;19(1):45-53. doi: 10.1001/journalofethics.2017.19.1.stas1-1701.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
State of the Art and Science Nov 2004 Chronic Myeloid Leukemia and the Application of Rational Drug Design Richard Maury Stone, MD Virtual Mentor. 2004;6(11):497-500. doi: 10.1001/virtualmentor.2004.6.11.cprl1-0411.